Prescription pattern of evidence-based pharmacotherapy in heart failure: An age perspective
نویسندگان
چکیده
منابع مشابه
Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes.
BACKGROUND Undertreatment with recommended pharmacotherapy is a common problem in heart failure and may influence prognosis. We studied initiation and persistence of evidence-based pharmacotherapy in 107,092 patients discharged after first hospitalization for heart failure in Denmark from 1995 to 2004. METHODS AND RESULTS Prescriptions of dispensed medication and mortality were identified by ...
متن کاملHeart Failure: A Class Review of Pharmacotherapy.
A recent guideline update for the treatment of heart failure has created the need for a new look at the medication classes and trials related to the disease. The authors focus on pharmacological options available for treating the problem.
متن کاملOptimising heart failure pharmacotherapy: the ideal combination.
Good management of all patients with heart failure is complex. Fortunately most patients fall into only one or two categories, making management less daunting. Most patients with heart failure need treatment with loop diuretics and ACE inhibitors and for many these drugs, possibly combined with antithrombotic measures, are all that is needed for optimal treatment, but optimal treatment can only...
متن کاملPrescription Pattern of Corticosteroids in Zanjan, Iran
The aim of the present study was to provide a clear picture of the prescribing pattern of corticosteroids in Zanjan, Iran. A retrospective and cross-sectional study was conducted to describe the pattern of corticosteroids prescription at Beheshti pharmacy (Zanjan, Iran) over a period of six months between March 21 and September 22 of 2013. Descriptive analyses were stratified by gender, age, typ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Preventive Cardiology
سال: 2021
ISSN: 2047-4873,2047-4881
DOI: 10.1093/eurjpc/zwab061.033